Literature DB >> 19932426

Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.

Robert McMillan1.   

Abstract

Chronic immune thrombocytopenia (ITP) is an autoimmune disorder manifested by immune-mediated platelet destruction and suppression of platelet production. Chronic ITP characteristically has an insidious onset, usually requires therapy, and is most commonly seen in adults. The diagnosis of chronic ITP is one of exclusion and is based on the American Society of Hematology Guidelines: The patient's history, physical examination, and peripheral blood film must be consistent with the diagnosis and other causes of thrombocytopenia must be ruled out. This article reviews the role of antiplatelet autoantibody in adult chronic ITP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932426     DOI: 10.1016/j.hoc.2009.08.008

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  19 in total

1.  The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies.

Authors:  Conglei Li; Siavash Piran; Pingguo Chen; Sean Lang; Alessandro Zarpellon; Joseph W Jin; Guangheng Zhu; Adili Reheman; Dianne E van der Wal; Elisa K Simpson; Ran Ni; Peter L Gross; Jerry Ware; Zaverio M Ruggeri; John Freedman; Heyu Ni
Journal:  J Clin Invest       Date:  2011-10-24       Impact factor: 14.808

2.  Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.

Authors:  Muna Iraqi; Jose Perdomo; Feng Yan; Philip Y-I Choi; Beng H Chong
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

3.  A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia.

Authors:  Shaun M Flint; Adele Gibson; Geoff Lucas; Raghava Nandigam; Louise Taylor; Drew Provan; Adrian C Newland; Caroline O Savage; Robert B Henderson
Journal:  Haematologica       Date:  2016-03-11       Impact factor: 9.941

4.  The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia.

Authors:  Andreia Maria Camargos Rocha; Cláudia Souza; Gifone Aguiar Rocha; Fabrício Freire de Melo; Nelma Cristina Diogo Clementino; Marília Campos Abreu Marino; Adriana Bozzi; Maria Luiza Silva; Olindo Assis Martins Filho; Dulciene Maria Magalhães Queiroz
Journal:  Haematologica       Date:  2011-10       Impact factor: 9.941

5.  Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia.

Authors:  Shuang Yu; Chuanfang Liu; Lanhua Li; Tian Tian; Min Wang; Yu Hu; Cunzhong Yuan; Lei Zhang; Chunyan Ji; Daoxin Ma
Journal:  Lab Invest       Date:  2014-12-08       Impact factor: 5.662

Review 6.  Immune thrombocytopenia.

Authors:  Gaurav Kistangari; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2013-06       Impact factor: 3.722

Review 7.  Diagnosis and management of autoimmune cytopenias in childhood.

Authors:  David T Teachey; Michele P Lambert
Journal:  Pediatr Clin North Am       Date:  2013-10-05       Impact factor: 3.278

8.  Classical complement pathway activation in immune thrombocytopenia purpura: inhibition by a novel C1s inhibitor.

Authors:  Ellinor I B Peerschke; Sandip Panicker; James Bussel
Journal:  Br J Haematol       Date:  2015-08-25       Impact factor: 6.998

9.  Prostate-specific membrane antigen as a marker of pancreatic cancer cells.

Authors:  He Ren; Huan Zhang; Xiuchao Wang; Junxiu Liu; Zhanna Yuan; Jihui Hao
Journal:  Med Oncol       Date:  2014-01-30       Impact factor: 3.064

Review 10.  Innate and adaptive immunity in immune thrombocytopenia.

Authors:  Alan H Lazarus; John W Semple; Douglas B Cines
Journal:  Semin Hematol       Date:  2013-01       Impact factor: 3.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.